Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-14

Clinical Trial Update: Adding Desmopressin to Tamsulosin for Treatment of BPH [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update exploring adding desmopressin to tamsulosin for nocturnal polyuria in patients with benign prostatic hyperplasia (BPH).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desmopressin (Desmopressin)
  • Tamsulosin (tamsulosin)

Snippet

Sponsor: Mansoura University | Conditions: Nocturnal Polyurea in Patients With BPH | Phase 4 | Status: UNKNOWN